Rheumatology

The licensing of biosimilars heralds the start of a new era for physicians treating immune and inflammatory diseases.

Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality.

The symposium at the EULAR 2017 congress aimed to provide insights into the burden of psoriatic arthritis on patients’ daily lives, including the…

Uveitis is an inflammatory disease with significant disease burden, as it causes ≤10% of legal blindness in the USA.

In this review, the role of the organic osmolytes taurine, betaine, myo-inositol, and sorbitol in skeletal muscles in general, and in myositis in…

Systemic lupus erythematosus is a chronic, multi-organ disease that predominantly affects young women of childbearing age.

Rheumatoid arthritis, the most frequent chronic inflammatory autoimmune disease, can lead to pain, bone and articular destruction, and limb…

Vitamin D acts as a steroid hormone possessing important functions in calcium and phosphorus balance and bone health.